NERI Continues to Be in Forefront in Pediatric Clinical Research with $105M in Funding
15:46 EDT 23 Jun 2012 | Businesswire
This article has expired, however you can still
download the PDF.
Preview:
Seventy percent (70%) of medications prescribed to children have only
been tested in adults. Children are not little adults. While there are
FDA initiatives, such as Pediatric Research Equity Act (PREA) and Best
Pharmaceuticals ...
Other Sources for this Article
NERI
Sandi Siami, 617-972-3317
ssiami@neriscience.com
More From BioPortfolio on "NERI Continues to Be in Forefront in Pediatric Clinical Research with $105M in Funding"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
